Aurora Sterilisation has secured €10.8 million in public funding to help medical device manufacturers transition to safer, greener sterilisation processes using natural plasma technology.

Embecta Corp. has closed its acquisition of UK-based Owen Mumford Holdings Limited for up to £150 million, bringing aboard the next-generation Aidaptus® auto-injector platform. The deal reshapes embecta’s future as a broad-based medical supplies company serving patients across diabetes, obesity, autoimmune diseases, and anaphylaxis.